The effects of Portulaca oleracea L (purslane) on psychologic symptoms and malondialdehyde level in schizophrenic patients

Rafiee Vardanjani, Leila. and Parvin, Neda. and Farzaneh Dehkordi, Shokoh. and Shahinfard, Najmeh. and Mortazaei, Seifollah. and Ansari Samani, Roya. (2013) The effects of Portulaca oleracea L (purslane) on psychologic symptoms and malondialdehyde level in schizophrenic patients. Scientific Journal of Kurdistan University of Medical Sciences, 18 (4). pp. 28-34.

[img]
Preview
Text
34.pdf

Download (197kB) | Preview
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Background and Aim: Despite the availability of antipsychotic drugs, a large number of patients with schizophrenia do not show a good response to monotherapy with these drugs. In this study we evaluated the effect of purslane on psychologic symptoms and malondialdehyde (MDA) level in schizophrenic patients in Sina Hospital. Materials and Methods: This randomized clinical trial study was carried out on 60 chronic schizophrenic patients treated with risperidone in Sina Hospital in Joneghan, Iran between 2011 and 2012. Patients were randomly divided into intervention and control groups. The control group received risperidone 6mg/day and biperiden 4mg/day for 8 weeks. The Patients in the intervention group received 1g extract of purslane daily in addition to risperidone and biperiden for 8 weeks. The scales for assessment of positive symptoms (SAPS), assessment of negative symptoms (SANS) and MDA level were recorded at the baseline and at the end of the 8th week of study. Data analysis was performed by using mean, SD, student t-test and paired t- test. Results: At the end of the study, the respective mean scores of positive symptoms were 47.93±18.56 in the intervention and 57.1±14.83 in the control group (P<0.05), and the mean scores of negative symptoms were 40.83±11.03 in the intervention and 46.13± 9.34 in the control group (P<0.05).In addition, the MDA levels of the patients in the intervention and control groups were 3.25±1.25 and 5.43± 1.76 respectively (P<0.05). Conclusion: According to findings of this study, simultaneous use of purslane and respridone can lead to improvement of psychological condition and decreased MDA level in the patients with chronic schizophrenia.

Item Type: Article
Additional Information: cited By 0
Uncontrolled Keywords: malonaldehyde; Portulaca oleracea extract, article; human; Portulaca oleracea; psychological aspect; randomized controlled trial; schizophrenia
Subjects: WM Psychiatry
QV pharmacology > QV 752 Pharmacognosy
Divisions: Faculty of Medicine > Basic Sciences Academic Groups > Department of Anatomy (Histology and Embryology
Faculty of Medicine > Basic Sciences Academic Groups > Department of Parasitology and Mycology
Faculty of Medicine > Department of Clinical Sciences > Department of Community Medicine
Faculty of Nursing and Midwifery
Faculty of Nursing and Midwifery > Department of Midwifery
Reserach Vice-Chancellar Department > Medical Plants Research Center
Depositing User: zahra bagheri .
Date Deposited: 09 Aug 2017 06:35
Last Modified: 15 Apr 2018 05:30
URI: http://eprints.skums.ac.ir/id/eprint/2719

Actions (login required)

View Item View Item